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Introduction
Italian National Health Service (NHS) is based on a federal model where each 
Administrative Region is responsible for the organization of the local healthcare system 
and for funding addressed to health need of residents.
Starting from 90s, the system was reformed in order to strengthen the role of each 
Region and since 2001 Administrative Regions granted exclusive legislative powers in 
this policy domain. According the new rules, Regions are held responsible for covering 
for expenditure exceeding health care standard fixed by National Care Plan and negative 
balance due to inter-regional mobility. In fact, patients are free to choose any accredited 
facility in Italy, inside or outside the Region of residence.
Health mobility has become a semi-structural element of Italian NHS that can be 
associated to relevant risk regarding inequity of access, inappropriate services and 
difficulty in maintaining the sustainability of regional health system [1].
The need to govern this phenomenon justifies an effort to gather more evidence, 
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Abstract
Objectives: The aim of this study is to evaluate the inter-regional mobility expenditures, 
with particular reference to oncology, in Liguria Region.
Study design: A descriptive analysis of inter-regional mobility expenditures from 2008 
to 2015 was carried out.
Methods: The analysis involved a detailed assessment of global balance of inter-
regional health mobility by means the DRGs; the flow of specialist outpatient and 
pharmaceutical was also used.
Results: Since 2008 until 2012 an increase of negative balance of global healthcare 
expenditure in Liguria Region was observed [34.7 € mill (2008) and 62.3 € mill (2012)]; 
subsequently a quite stable trend was recorded between 2012 and 2015 [ranging between 
59.8 € mill (2013) and 63.2 € mill (2014)]. The passive mobility was 15.1% on the total 
spending for hospital acute care in 2012 and a similar value was detected in 2015 (15.2%). 
The higher costs for passive mobility were attributable to the surgical DRGs (69.4% in 2012 
and 69.8% in 2015) with a double estimate of the expenditure in comparison with medical 
ones (2012: 99.4 € mill vs 43.8 € mill, Δ= 55.6 € mill; 2015: 96.6 € mill vs 41.9 € mill, Δ= 54.7 
€ mill). The highest cost sources in the process of passive mobility are the surgical areas, 
particularly the surgical hospitalizations for orthopaedic and cardiologic interventions. The 
spending analysis for oncologic DRG, divided into surgical and medical for passive and 
active mobility, showed that the surgical DRG determined a negative balance of 3.8 € mill 
in 2012 and 4.3 € mill in 2015, while the medical DRG showed a positive balance of 0.5 € 
mill in 2012 and 0.7 € mill in 2015.
Conclusions: Our evaluation highlights that the inter-regional mobility for hospital 
acute care is the most relevant issue for the economic regional balance and reveals an 
important flow of patients moving from Liguria Region to neighbouring regions. As the 
equity of access and distribution of the supply of care remains a priority of Regional Health 
System, the active mobility in oncologic field could be a marker of quality health planning. 
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while maintaining the principle of the patient’s freedom of choice 
to decide in what structure of the NHS receive health service. In 
fact, one of the fundamental rights Italian citizens have in the field 
of healthcare is the “freedom of choice of provider and place of 
treatment” [2-6].
In 1995, the Italian NHS began to fund hospitals on a system 
based on cases classified according to Diagnosis Related Group 
system (DRG). Five out of 21 Italian regions have developed a 
system of regional DRG fares, while the majority adopted the 
system established on a national level [7].
Since 2003, the so-called “single fare” (TUC- Tariffa Unica 
Convenzionale) applies to the hospital treatment provided 
outside the Region of residence. This fare is DRG specific and is 
fixed on a national level. At the end of each year, the TUC fares are 
used to calculate the “active-passive” balance and to determine 
the financial resources that need to be transferred to each region. 
Liguria is one of the smallest and yet most densely populated 
regions in Italy with over 1,500,000 inhabitants and a density of 
288 inhabitants/km2, much above the national average, which 
varies considerably between inland and coastal areas, touching 
1,000 inhabitants/km2 in the latter [8,9]. One of the most relevant 
issues is the aging of the population with a 27% over 65 years, a 
11.4% under 14 years old, an index of old age of 234.5 (the ratio 
of elderly people and children), the highest in Europe, and an 
index of structural dependency equal to 61.9 (ratio of the sum of 
the geriatric, paediatric and adult population) [8,9].
Liguria shows a heterogeneous active-passive balance 
according to specialization field with a incoming mobility 
for some specialties, i.e. paediatric, haematology and strong 
outbound mobility towards large neighbouring regions.
Cancer care is a paradigmatic field for mobility both for 
obvious reasons of technical-scientific and psychosocial 
complexity, but also for the increasing costs of treatments and 
the growth of the private medical agreement in the neighbouring 
regions, especially Lombardia with greater Milan at 150 km from 
Genoa. In recent years, the burden of care for cancer patients 
has been gradually increasing for three basic reasons: first, the 
progressive increase in the number of observed cases (although 
unchanged at incidence rates) due to the progressive aging of 
the population (expected 20-30% more cases in 2020) [10,11]; 
second, new therapeutic options targeted to obtain the healing 
or chronicity of the disease, with increased of the overall survival 
and prevalence of cancer cases; third, the applicability of new 
therapeutic agents also to fragile patients (elderly, complexes by 
co-morbidity, etc).
The aim of this study is to provide a descriptive analysis of 
inter-regional mobility expenditures overall, with particular 
reference to oncology. The analysis involved a detailed assessment 
of the DRG to identify flow characteristics by Local Health Units 
(LHU) of departure, arrival Region, type of service. All sources of 
health activities, be them hospital based or ambulatory based, 
acute and chronic, were included given that the goal was to get 
a wider understanding of the phenomenon to allow corrective 
proposals for the improvement of the health governance through 
greater appropriateness and reduction of spending. The issue of 
inter-regional mobility may also have international implications 
for those mixed public private health care systems, particularly 
in Europe, where intense marketing strategies by private 
institutions is present, such as for instance in Lombardia region 
around the greater Milan.
Methods
Liguria Region is located in the North-western of Italy, it 
has five LHUs covering 1,591,939 inhabitants: LHU1 (217,703 
residents), LHU2 (283,813 residents), LHU3 (723,182 residents), 
LHU4 (148,106 residents) and LHU5 (219,135 residents).
The global balance of inter-regional health mobility was 
evaluated in the period between 2008 and 2015 to better 
contextualize the phenomenon; the analysis of main descriptive 
elements, i.e., macro cost items, direction of mobility, area of 
DRGs, etc. considered the period from 2012 to 2015.
The information flow
The health consultation “Data warehouse” service is 
accessible from the portal www.liguriainformasalute.it through 
identification of the enabled operator.
The data source consists in the flow of hospital discharge cards 
(SDO) - informative debt of Healthcare Agencies- which, monthly, 
is sent to the Liguria Region and in the flow of information sent 
from other Regions or autonomous Provinces with regard to 
hospitalization for services provided to Ligurian residents in 
facilities of such regions or provinces (passive mobility). 
The data of the activity of the Liguria Healthcare Authority 
(ALiSa) are consolidated within the 10th of March of the 
following year to the reference one while the passive mobility 
is sent within the month of May of the following year to the 
end of the period. All data are classified according to ICD-9-CM 
2007 (diagnoses and procedures) and HCFA DRG 24 (outcome 
of the hospitalization) systems and are constantly updated for 
epidemiological purposes. The flow of specialist outpatient and 
pharmaceutical was also used. 
The analysis of the Mobility
This is a descriptive analysis aimed at understanding which 
are the clinical specialties that most contribute to determine 
the health mobility in Liguria. We use two basic indices to 
measure patient flows: i) the attraction rate calculated at the 
ratio of number of patients coming outside Liguria admitted to 
any regional hospital to the total number of admission at that 
hospital; ii) the escape rate calculated as the ratio of the number 
of resident patients flown to other regions to the total number of 
residents of Liguria admitted to any Italian hospital. The analysis 
of the mobility shows that the costs of hospitalization procedures 
that Ligurian citizens, divided by area of residence, have received 
from various public and accredited private structures in Italy, 
classified according to different criteria:
1. According to the hospitalization: for this classification 
have been used the SDO fields marked with information 
related to the type of hospitalization (ordinary or day-
care) and the homogeneous functional area (which allows 
identifying the rehabilitation).
2. According to the diagnostic grouping: the DRG system, 
which in the current version includes 538 codes, also
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includes the episodes of hospitalization in 25 broad 
categories (MDC or main diagnostic groups) generally 
corresponding to organ pathology.
Considering the particularity of the field of oncology 
(multidisciplinary, transversal compared to DRG and with a high 
social and economic impact) a specific evaluation on oncological 
DRG was performed (Supplemental file 1).
Results
Since 2008 until 2012 an increase of negative balance of 
global healthcare expenditure in Liguria Region was observed 
[34.7 € mill (2008) and 62.3 € mill (2012)]; subsequently a quite 
stable trend was recorded between 2012 and 2015 [ranging 
between 59.8 € mill (2013) and 63.2 € mill (2014)] (Figure 
1 and Table 1). The economic data related to the period 2012- 
2015 for the passive and active mobility divided by macro cost 
items showed that the main negative voices were represented by 
ordinary hospitalizations outside the region [range: -44.4 € mill 
(2012); -47.1 € mill (2014)], followed by outpatient services/
treatments [range: -10.7 € mill (2012); -12 € mill (2014)], 
day care hospitalizations [range: 0.7 € mill (2015); 1.9 € mill 
(2013)], and direct pharmaceutical expenditure (direct drug 
administration) [range: -2.7 € mill (2014); -4.1 € mill (2012)]. 
In 2015, the hospital spending average per resident was equal 
to € 571.99. The LHU2 and LHU5 showed the highest per-capita 
expenditure, with a value of 2.6% and 1.7% higher than regional 
average, respectively. In 2015, the per-capita expenditure of 
passive mobility was 80.5€  in LHU1, 79.4€  in LHU2, 65.9€  in 
LHU3, 87.9€  in LHU4 and 171.6€ in LHU5. With regard to per-
capita costs for inter-regional passive mobility due to hospital 
admissions, LHU1 has showed a slight increase of expenditure 
between 2012 and 2014 (76.8€ - 81.2€) and a quite decrease 
for the subsequent year (80.5€ ). A slight reduction of per-capita 
costs was observed for LHU2 (88.4€ in 2012 - 79.4€ in 2015) 
and LHU4 (90.5€ in 2012 -87.9€  in 2015). The trend of per-
capita values in LHU3, that serves the most populated area, was 
stable, ranging from 64.8€ and 65.9€ in 2012 and 2015, 
respectively. Major expenditures were recorded for LHU5 in 
comparison with other LHUs (174.9€  in 2012 and 171.6€ in 
2015). 
The descriptive analysis of the phenomenon: the direc-
tions of mobility
In order to determine the volumes and, contextually, highlight 
the main mobility directions, we proceeded to the description 
of the phenomenon for all types of hospitalization (Figure 2) 
showed the expenditure of the hospital passive mobility for the 
most attractive regions. In particular, the passive mobility was 
15.1% on the total spending for hospital acute care in 2012 and 
a similar value was detected in 2015 (15.2%) confirming a stable 
trend.
It was observed that the most attractive Regions are the 
neighbouring ones, specifically in descending order: Lombardy, 
Piedmont, Tuscany and Emilia Romagna. The percentage relating 
to passive mobility remains almost unchanged for the period 
under study in each Region (Figure 2).
The majority of the migrations occurred in ordinary 
hospitalization compared to those in day care regimen. Indeed, 
considering the total economic burden, in 2012 € 128.1 
million were destined for ordinary hospital admissions, while 
minor amounts were due to day-care admissions (15.0 € mill); 
similarly, the costs amounted 125.4 €million (ordinary hospital 
admissions) vs 13.4€ million (day-care admissions) in 2015. 
Specifically, the maximum expenditure for day-care admission 
was attributed to residents of LHU5 (5.0 € mill in 2012 and 4.2 € 
ONCOLOGICAL DRG
010 - NERVOUS SYSTEM NEOPLASMS WITH COMPLICATIONS 307 – PROSTATECTOMY WITHOUT COMPLICATIONS
011 - NERVOUS SYSTEM NEOPLASMS WITHOUT COMPLICATIONS 338 - TESTES PROCEDURES FOR NEOPL
064 - EAR, NOSE, MOUTH & THROAT MALIGNANCY 318 - KIDNEY & URINARY TRACT NEOPLASMS WITH COMPLICATIONS
075 - MAJOR CHEST PROCEDURES 319 - KIDNEY & URINARY TRACT NEOPLASMS WITHOUT COMPLICATIONS
082 - RESPIRATORY NEOPLASMS 346 - MALIGNANCY, MALE REPRO SYSTEM, WITH COMPLICATIONS
146 – RECTAL RESECTION WITH COMPLICATIONS 347 - MALIGNANCY, MALE REPRO SYSTEM, WITHOUT COMPLICATIONS
147 - RECTAL RESECTION WITHOUT COMPLICATIONS 353 - PELVIC EVISC,RAD HYSTERECT & RAD VULVECT
149 - MAJOR SMALL & LARGE BOWEL PROCS WITHOUT COMPLICATIONS 354 - UTER,ADNEX PROC NON-OV/ADNEX MALIG WITH COMPLICATIONS
172 - DIGESTIVE MALIGNANCY WITH COMPLICATIONS 355 - UTER,ADNEX PROC NON-OV/ADNEX MALIG WITHOUT COMPLICATIONS
173 - DIGESTIVE MALIGNANCY WITHOUT COMPLICATIONS 357 - UTER&ADNEX PROC FOR OVAR,ADNEXAL MALIG
191 - PANCREAS,LIVER & SHUNT PROCEDURES WITH COMPLICATIONS 366 - MALIGNANCY, FEMALE REPRO SYSTEM WITH COMPLICATIONS
192 - PANCREAS,LIVER & SHUNT PROCEDURES WITHOUT COMPLICATIONS 367 - MALIGNANCY, FEMALE REPRO SYSTEM WITHOUT COMPLICATIONS
193 - BIL PROC, EX ONLY CHOLCYST W/WO CDE WITH COMPLICATIONS 401 - LYMPHOMA&NONACU LEUK OTH O.R PROC WITH COMPLICATIONS
194 - BIL PROC, EX ONLY CHOLCYST W/WO CDE WITHOUT COMPLICATIONS 402 - LYMPHOMA&NONACU LEUK OTH O.R PROC WITHOUT COMPLICATIONS
199 - HEPATOBIL DIAGNOSTIC PROCEDURE FOR NEOPL 403 - LYMPHOMA & NON-ACUTE LEUKEMIA WITH COMPLICATIONS
203 - MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 404 - LYMPHOMA & NON-ACUTE LEUKEMIA WITHOUT COMPLICATIONS
257 - MASTECTOMY FOR MALIGNANCY WITH COMPLICATIONS 405 - ACUTE LEUKEMIA W/O MAJ O.R PROC AGE <18
258 - MASTECTOMY FOR MALIGNANCY WITHOUT COMPLICATIONS 406 - MYEL DIS/PRLY DIF NEO&MAJ O.R.PROC WITH COMPLICATIONS
259 - MASTECTOMY FOR MALIGNANCY WITH COMPLICATIONS 407 - MYEL DIS,PRLY DIF NEO&MAJ O.R.PROC WITHOUT COMPLICATIONS
260 - MASTECTOMY FOR MALIGNANCY WITHOUT COMPLICATIONS 408 - MYEL DIS,PRLY DIF NEO&OTH O.R.PROC WITH OTHER INTERVENTIONS
303 - KIDNEY,URETR & MAJ BLADDR PROC FOR NEOPL 409 - RADIOTHERAPY
306 – PROSTATECTOMY WITH COMPLICATIONS 410 - CHEMOTHERAPY WITHOUT ACUTE LUKEMIA AS SEC DX
Supplemental file 1. Oncological DRGs evaluated in the analysis.
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    Figure 1:  Negative balance (€ mill) of health spending in the Liguria Region (2008-2015).
TOPIC SUB-TOPIC
2015 2012
Credit (€) Debt (€) Balance (€) Credit (€) Debt (€) Balance (€)
HOSPITAL 
ADMISSIONS
DAY-CARE 14,095,562 13,447,862 647,700 16,465,013 15,021,101 1,443,912
ORDINARY 80,191,237 125,386,836 - 45,195,599 83,762,635 128,139,497 - 44,376,861
GENERAL MEDICINE 711,681 1,271,565 - 559,884 713,225 1,261,534 - 548,309
SPECIALIST OUTPATIENT SERVICES 14,972,301 25,641,756 - 10,669,454 13,383,647 24,212,331 - 10,828,684
PHARMACEUTICAL
TERRITORIAL PHARMACEUTICAL 3,450,994 3,658,716 - 207,722 3,546,164 4,000,645 - 454,480
DIRECT DRUG ADMINISTRATION 8,181,705 11,467,957 - 3,286,251 5,204,400 9,311,005 - 4,106,605
THERMAL CARE 38,127 1,657,375 - 1,619,248 50,434 1,963,693 - 1,913,259
AMBULANCE/HELICOPTER RESCUE TRANSPORT 2,567,101 2,419,268 147,833 478,653 1,931,086 - 1,452,433
RESIDUAL MENTAL HOSPITALS 0 0 0 0,00 108,928 - 108,928
TOTAL 124,208,708 184,951,335 - 60,742,626 123,604,172 185,949,820 - 62,345,648
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Figure 2:.Costs (€ mill and % value) of the most attractive Regions for each type of hospital admissions (ordinary and day-care), period 2012-2015. 
mill in 2015) and for the ordinary hospitalization to residents of 
LHU3 (44.4 € mill in 2012 and 44.2 € mill in 2015). 
Figure 3 shows the costs for hospitalization inside and 
outside our Region of Ligurian residents, according LHUs 
in 2012 and 2015, and the percentages of expenditure for 
passive mobility out of hospital expenditure. In particular, in 
2012, the average value of passive mobility observed in LHU5 
was double than the regional one (29.3% vs 15.1%); the same 
ratio is observed in 2015 (29.6% vs 15.2%). Interestingly, the 
LHU3, where regional reference hospitals are sited, showed 
the lowest average proportion (2012: 11.1% vs 15.1%; 2015: 
11.4% vs 15.2%) (Figure 3). 
The global expenditure for hospitalization decreased in every 
LHUs, while the percentages of expenditure for passive mobility 
out of hospital expenditure was stable during the period, with 
fluctuation lower than 1.5% in every Units.
The Top 20 of the DRG: who comes and who goes
We proceeded to analyze the phenomenon of mobility, both 
active and passive, for DRG by issuing a decreasing spending rank 
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in period 2012 and 2015. Table 2 shows the top 20 DRGs with a 
highest economic impact. The higher costs for passive mobility 
were attributable to the surgical DRGs (69.4% in 2012 and 69.8% 
in 2015) with a double estimate of the expenditure in comparison 
with medical ones (2012: 99.4 € mill vs 43.8 € mill, Δ= 55.6 € 
mill; 2015: 96.6 € mill vs 41.9 € mill, Δ= 54.7 € mill) (Table 3a). 
In details, the orthopaedic and cardio-surgical interventions 
represented the 30.2% and 15.6% of the total amount of passive 
mobility, respectively. The DRG544 (major joint replacement or 
reattachment of lower extremity) was the most implicated in the 
passive mobility with an economic value of 15.3 € mill in 2015 
and 16.0 € mill in 2012. The DRG410 (chemotherapy) was the 
only oncologic DRG present in the top 20 list of passive mobility. 
The attractiveness showed digits slightly in favour of the surgical 
DRGs (2012: 57 € mill vs 43.2 € mill, Δ= 13.8 € mill; 2015: 57.3 
€ mill vs 37.7 € mill, Δ= 19.6 € mill) (Table 3a). The surgical area 
covered the 60.3% of total costs. The DRG481 (bone marrow 
transplantation) appears to be the first with 6.3 € mill brought 
in Liguria Region in the 2015 and 9.4 € mill in the 2012 (data not 
shown). The DRG410 (chemotherapy) and DRG075 (major chest 
procedure) are the only two oncologic DRG which appear in the 
Top20 list of active mobility. 
The Mobility process in oncology: An overview
The spending due to oncologic escapes was 12.3 € mill in 2012 
(8.6% of total passive mobility) and 11.8 € mill in 2015 (8.5% 
of total passive mobility). The spending analysis for oncologic 
DRG, divided into surgical and medical for passive and active 
mobility, showed that the surgical DRG determined a negative 
balance of 3.8 € mill in 2012 and 4.3 € mill in 2015, while the 
medical DRG showed a positive balance of 0.5 € mill in 2012 and 
0.7 € mill in 2015 (Table 3b). The expenditure on cancer drugs at 
high cost (L01, L02, L03) for 2012 showed a negative balance of 
approximately 0.4 € mill and a containment of costs in 2015 with 
a positive balance of 0.7 € mill (Table 3c).
Discussion
Liguria is the region with the highest aging index in Europe 
and a steadily increasing burden of chronic patients. Therefore, 
the response to chronicity is one of the major challenges to which 
the Regional Health System is called to respond both in terms of 
quality of supply to the needs of the citizen and in terms of system 
sustainability. In Liguria, since 2008 until 2012 an increase of 
negative balance of global healthcare expenditure was observed, 
while in recent years a quite stable trend was recorded, showing 
that it became a structural issue of Regional health supply with 
potential risks for sustainability of health system. In fact, inter-
regional mobility for hospital acute care is the most relevant issue 
for the economic regional balance. Our evaluation highlighted 
an important flow of patients moving from Liguria Region to 
neighbouring regions. The Regions most attractive in terms 
of migrations are: Lombardy, Piedmont, Tuscany and Emilia 
Romagna. As reported an another study, the Northern - Central 
regions such as Lombardy, Emilia Romagna and Tuscany have the 
largest number of attractions in absolute value [12].
As expected, the highest cost sources in the process of 
passive mobility are the surgical areas, particularly the surgical 
hospitalizations for orthopaedic and cardiologic interventions. 
Strengthening of clinical pathway in these areas represents one 
of the priorities to contrast the aggressive attractive policy by 
neighbouring regions. 
Passive mobility for oncology represents <9% out of global 
escape costs. In particular, oncologic surgical DRGs turn out 
to be more involved in the migrations with about 4.3 € mill of 
negative balance, while the DRGs of medical oncology have led to 
a positive balance of 0.7 € mill in 2015. It is therefore evident how 
the oncologic passive mobility is a problem of moderate severity 
for the surgical area, partially compensated for attractiveness by 
medical supply. Compared with the negative balance item, other 
surgical  areas - above all those of the orthopaedic knee and 
hip replacement - are more critical and require specific action to 
contrast a phenomenon that risks to blow up the regional 
balance. The oncologic network model for the early taking charge 
of the patient and the government of the appropriateness of the 
processes seems to be the model that on a national and regional 
level has been most successful. 
The strategic actions planned by Liguria Healthcare Authority 

















































Figure 3: Costs of hospital admissions inside and outside the Liguria Region for LHUs (€ mill and % average).
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DRG N. DRG
481 - BONE MARROW TRANSPLANT 89 6.26
544 - MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY 519 4.59
410 - CHEMOTHERAPY WITHOUT ACUTE LUKEMIA AS SEC DX 785 2.29
541 - TRACH MV 96+H OR PDX EX F/M/N W MAJ OR 32 1.99
144 - OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATIONS 354 1.75
503 - KNEE PROCEDURES WITHOUT PDX OF INFECTION 825 1.66
087 PULMONARY EDEMA & RESPIRATORY FAILURE 392 1.45
075 - MAJOR CHEST PROCEDURES 133 1.39
557 - PERCUTANEOUS CARDIOVASCULAR PROCEDURE WITH DRUG-ELUTING STENT WITH MAJOR 
CARDIOVASCULAR DIAGNOSIS 148 1.21
108 - OTHER CARDIOTHORACIC PROCEDURES 53 1.12
104 - CARDIAC VALVE PROC WITH CARD CATH 42 1.09
545 - REVISION HIP AND KNEE REPLACEMENT 96 1.07
003 - CRANIOTOMY AGE <18 91 1.04
574 - MAJOR HEMATOLOGICAL/IMMUNOLOGIC DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION 
DISORDERS . 287 1.03
269 - SKIN. SUBCUT TISSUE & BREAST OTHER PROCEDURES WITH COMPLICATIONS 166 1.00
145 - OTHER CIRCULATORY SYSTEM DIAGNOSES WITHOUT COMPLICATIONS 266 0.97
009 - SPINAL DISORDERS & INJURIES 261 0.96
316 - RENAL FAILURE 348 0.95
256 - OTHER MUSCSKL SYST & CONN TISS DIAGNOSES 607 0.95
012 - DEGENERATIVE NERVOUS SYSTEM DISORDERS 265 0.93
€ (MILL)
544 - MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY 1,751 15.34
104 - CARDIAC VALVE PROC WITH CARD CATH 166 4.49
256 - OTHER MUSCSKL SYST & CONN TISS DIAGNOSES 1,041 3.61
503 - KNEE PROC WITHOUT PDX OF INFECTION 1,297 2.58
012 - DEGENERATIVE NERVOUS SYSTEM DISORDERS 377 2.52
105 - CARDIAC VALVE PROC WITHOUT CARD CATH 95 2.27
545 - REVISION HIP AND KNEE REPLACEMENT 201 2.21
462 - REHABILITATION 407 2.05
541 - TRACH MV 96+H OR PDX EX F/M/N W MAJ OR 37 2.01
002 - CRANIOTOMY AGE >17 WITHOUT COMPLICATIONS 153 1.88
014 - INTRACRAN HEM OR CEREBRAL INFARCT 191 1.88
225 - FOOT PROCEDURES 1,017 1.82
410 - CHEMOTHERAPY WITHOUT ACUTE LUKEMIA AS SEC DX 588 1.79
498 - SPINAL FUSION EXCEPT CERVICAL NO COMPLICATIONS 143 1.76
359 - UTER&ADNEX PROC FOR NON-MALIG WITHOUT COMPLICATIONS 786 1.67
245 - BONE DISEASES & ARTHROPATHIES WITHOUT COMPLICATIONS 505 1.67
480 - LIVER TRANSPLANT &/OR INTESTINAL TRANSPLANT 21 1.46
035 - OTHER DISORDERS OF NERVOUS SYSTEM 180 1.30
191 - PANCREAS.LIVER & SHUNT PROCEDURES WITH COMPLICATIONS 89 1.29
288 - SURGICAL PROCEDURES FOR OBESITY 216 1.23
430 - PSYCHOSES 418 1.21
Table 2:  Descending ranking of the Top 20 DRGs for passive and active inter-regional mobility (2015) In bold are highlighted the DRGs related to the oncology.
included support of the network model and implementation of 
governance by sharing of objective, indicators and targets on a 
regional level. For this reason, in 2017, with the deliberation n° 
131 of ALiSa, the regional inter-company departments (DIARs) 
are established as an organizational tool to promote quality, 
appropriateness of care, homogenous and evidence-based 
healthcare pathways in the regional area, and clinical efficacy with 
consequent optimization of resources. The equity of access and 
distribution of the supply of care remains a priority of Regional 
Health System; the active mobility in oncologic field could be a 
marker of quality health planning. In fact, most recent evidence 
indicates that the some of cancer drugs registered in Europe 
by European Medicines Agency (EMA) do not show a benefit in 
terms of survival or quality of life [13] and in Liguria region the 
institution of an hemato-oncological DIAR will allow to tightly 
monitor the prescriptive appropriateness of innovative 
oncologic therapies and the definition of recommendations. 
Health mobility picture from Liguria may be paradigmatic of the 
National phenomenon, although some areas (i.e. Southern 
Regions) show a more relevant and well known mobility 
towards Northern Regions. Confirmation from a health mobility 
analysis would strengthen our findings. 
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2012 2015 2012 2015
Structure outside
Liguria Region
Surgical DRG 99.4 96.6
Medical DRG 43.8 41.9
Structures in
Liguria Region
Surgical DRG 395.2 369.6 57 57.3
Medical DRG 403.2 402.3 43.2 37.7
B
Debtor Liguria (mill) Debtor Other Regions€ (mill)
2012 2015 2012 2015
Surgical Oncologic DRG 7.4 7.7 3.6 3.4
Medical Oncologic DRG 4.94 4.06 5.5 4.8
C Active Passive Balance
2012 2.522.522,85 2.872.335,41 -349.812,6
2015 5.066.207,02 4.376.237,21 689.969,81
Table 3a: Costs of passive and active inter-regional mobility for all DRGs divided by surgical and medical areas. b) Costs of passive and active inter-regional mobility 
for oncologic DRGs. c) Costs for cancer drugs (L01: anti-neoplastic agents, L02: anti-hormonal agents, L03: immune-stimulants) for active and passive inter-regional 
mobility. 
Conclusion
Our findings show that the highest cost sources in the 
process of passive mobility are the surgical areas, particularly 
the surgical hospitalizations for orthopaedic and cardiologic 
interventions. Oncology represents less than 9% of total 
expenditures, with surgery being greater than medical 
oncology. In order to implement the governance of the 
passive mobility, Liguria Healthcare Authority has proposed 
a new organizational model (DIARs) to promote and strengthen 
quality, appropriateness of care, homogeneous and evidence-
based healthcare pathways and clinical efficacy with consequent 
optimization of resources.
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